After Hours
$
26.74
Change
+0.01 +0.04%
Volume
Volume 4,341
Sep 26, 2023, 4:08 p.m.
Quotes are delayed by 20 min
Previous close
$ 26.25
$ 26.73
Change
+0.48 +1.83%
Day low
Day high
$26.18
$27.89

52 week low
52 week high
$13.73
$37.75

Market cap
$698.21M
Average volume
433,769
P/E ratio
9.24
Rev. per Employee
$1.55M
EPS
2.89
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ARCT
-
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock falls Friday, still outperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For February 28, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For January 22, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For November 29, 2017
- Benzinga.com
Other News on ARCT
-
10-Q: ARCTURUS THERAPEUTICS HOLDINGS INC.
- Edgar Online - (EDG = 10Q, 10K)
-
10-K: ARCTURUS THERAPEUTICS HOLDINGS INC.
- Edgar Online - (EDG = 10Q, 10K)
-
10-Q: ARCTURUS THERAPEUTICS HOLDINGS INC.
- Edgar Online - (EDG = 10Q, 10K)
Press Releases on ARCT
-
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
- BusinessWire - BZX
-
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
- BusinessWire - BZX
-
Arcturus Therapeutics to Present at the Following Investor Conferences in November
- BusinessWire - BZX
-
Arcturus Therapeutics to Attend the Following Investor Conferences
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com